Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.72B |
| 2 |
Apple
AAPL
|
+$1.98B |
| 3 |
Microsoft
MSFT
|
+$1.42B |
| 4 |
Alibaba
BABA
|
+$1.03B |
| 5 |
Amazon
AMZN
|
+$924M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Keurig Dr Pepper
KDP
|
+$173M |
| 2 |
FedEx
FDX
|
+$150M |
| 3 |
Oracle
ORCL
|
+$139M |
| 4 |
Linde
LIN
|
+$132M |
| 5 |
PayPal
PYPL
|
+$131M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.59% |
| 2 | Consumer Discretionary | 6.81% |
| 3 | Healthcare | 6.77% |
| 4 | Financials | 5.21% |
| 5 | Industrials | 4.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1051
M&T Bank
MTB
$35.7B
| $20M | 0.01% |
156,723
-104,607
| -40% | -$11.9M |
|
1052
Dr. Reddy's Laboratories
RDY
$9.87B
| $19.9M | 0.01% |
1,397,525
+1,357,860
| +3,423% | +$18.3M |
|
1053
Bausch Health
BHC
$2.57B
| $19.9M | 0.01% |
955,989
+425,057
| +80% | +$7.93M |
|
1054
Tronox
TROX
$932M
| $19.9M | 0.01% |
1,359,397
+840,486
| +162% | +$9.78M |
|
1055
NovoCure
NVCR
$1.73B
| $19.8M | 0.01% |
114,708
+75,265
| +191% | +$10.3M |
|
1056
Travere Therapeutics
TVTX
$5.2B
| $19.8M | 0.01% |
727,176
-138,933
| -16% | -$3.24M |
|
1057
Gen Digital
GEN
$16.4B
| $19.8M | 0.01% |
953,488
+861,789
| +940% | +$17.4M |
|
1058
Diageo
DEO
$49B
| $19.8M | 0.01% |
124,746
+81,394
| +188% | +$12.1M |
|
1059
Maravai LifeSciences
MRVI
$969M
| $19.8M | 0.01% |
+705,698
| New | +$19.7M |
|
1060
Avis
CAR
$4.86B
| $19.7M | 0.01% |
527,507
+126,107
| +31% | +$4.43M |
|
1061
CALL
Coca-Cola
KO
$377B
| $19.7M | 0.01% |
358,700
-523,200
| -59% | -$27.1M |
|
1062
RingCentral
RNG
$4.66B
| $19.6M | 0.01% |
51,805
-59,832
| -54% | -$18.6M |
|
1063
Acadia Pharmaceuticals
ACAD
$4.43B
| $19.6M | 0.01% |
367,111
-224,421
| -38% | -$11.1M |
|
1064
Flowserve
FLS
$9.71B
| $19.6M | 0.01% |
531,866
+287,224
| +117% | +$9.4M |
|
1065
W.P. Carey
WPC
$16.8B
| $19.6M | 0.01% |
283,418
-446,986
| -61% | -$29.9M |
|
|
IAA
1066
DELISTED
IAA, Inc. Common Stock
IAA
| $19.5M | 0.01% |
300,581
+246,577
| +457% | +$14.8M |
|
|
UMPQ
1067
DELISTED
Umpqua Holdings Corp
UMPQ
| $19.5M | 0.01% |
1,286,234
-180,029
| -12% | -$2.47M |
|
1068
Immunovant
IMVT
$7.93B
| $19.5M | 0.01% |
421,184
-152,279
| -27% | -$7.04M |
|
|
SOGO
1069
DELISTED
Sogou Inc. American Depositary Shares, each representing one Class A Ordinary Share
SOGO
| $19.4M | 0.01% |
2,385,260
+2,271,716
| +2,001% | +$19.7M |
|
|
MRSH
1070
Marsh
MRSH
$90.5B
| $19.4M | 0.01% |
166,094
+74,903
| +82% | +$8.51M |
|
|
SKX
1071
DELISTED
Skechers
SKX
| $19.4M | 0.01% |
540,673
+362,040
| +203% | +$12.3M |
|
1072
Jazz Pharmaceuticals
JAZZ
$15.9B
| $19.4M | 0.01% |
117,707
-137,105
| -54% | -$20.4M |
|
1073
Evercore
EVR
$12.4B
| $19.4M | 0.01% |
176,945
+135,966
| +332% | +$12.1M |
|
1074
Flex
FLEX
$41.7B
| $19.4M | 0.01% |
1,429,231
+857,344
| +150% | +$9.91M |
|
|
IVC
1075
DELISTED
Invacare Corporation
IVC
| $19.3M | 0.01% |
2,160,948
+835,699
| +63% | +$6.95M |
|
Similar funds
Millennium Management's Q4 2020 Portfolio in Review
As of Q4 2020, Millennium Management held 5,904 positions worth $138B, up 170,419% from $81.2M the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Millennium Management deployed $45.7B of net new capital in Q4 2020, opening 1,518 new positions and adding to 1,899 existing holdings. Its largest new stake was Sotera Health: 2,269,458 shares worth $62.3M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 6% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Keurig Dr Pepper, an estimated $173M trimmed.
- Millennium Management's largest Q4 2020 buy was Sotera Health: 2,269,458 shares worth $62.3M.
- Millennium Management added most to State Street SPDR S&P 500 ETF Trust in Q4 2020, an estimated $2.72B increase.
- Millennium Management's biggest Q4 2020 reduction was Keurig Dr Pepper, cutting an estimated $173M.
- Millennium Management fully exited Clover Health Investments in Q4 2020, selling an estimated $36.7M.
- Millennium Management's ten largest holdings make up 20% of its $138B portfolio in Q4 2020.
- Millennium Management opened 1,518 new positions and closed 754 in Q4 2020.
- Millennium Management's portfolio value rose 170,419% quarter-over-quarter to $138B.
Based on Millennium Management's 13F filing for Q4 2020, filed 16 Feb 2021.